India link in fresh US insider trading scam
- Solar scam case: Kerala court orders FIR against CM Oommen Chandy
- Supreme Court recalls order appointing former judge Virendra Singh as UP Lokayukta
- Arunachal Governor cited ‘cow slaughter’ protest as one sign of law & order collapse in state
- BJP leader held for alleged cow slaughter in Madhya Pradesh, gets expelled from party
- Indian-American Muslims flay Government move against AMU, Jamia
A prominent Indian-origin hedge fund portfolio manager has been charged with participating in one of the "most lucrative" insider trading schemes ever in the US.
Mathew Martoma, 38, has been charged with using material, non-public information that he received from a doctor on the clinical trial of an Alzheimer's drug to make profits and avoid losses for his hedge fund for an amount totalling approximately $276 million.
Martoma, who was arrested last week from his home in Boca Raton, Florida, was released on Monday on a $5 million bail after a brief hearing at the Manhattan federal court here. He did not enter any plea and the judge set the next hearing for December 26.
- Dalit scholar’s death exposed inability of casteist Hindu to be modern
- Annotated edition of Hitler's Mein Kemph
- Why yuan matters Indian equity markets
- R-day and the saccharine sweet patriotism
- It is clear PM’s concept of nationhood extends beyond constitutional parameters
- The sensitive and old controversy about the minority character of AMU